关键词: Elaeagnus umbellata antioxidant melanogenesis skin-whitening α-MSH

Mesh : Animals Antioxidants / pharmacology Cell Survival Elaeagnaceae / chemistry Hormones / pharmacology Melanins / metabolism Melanocytes / cytology drug effects metabolism Melanoma, Experimental / drug therapy pathology Mice Monophenol Monooxygenase / antagonists & inhibitors Phosphorylation Plant Extracts / pharmacology Skin Pigmentation / drug effects alpha-MSH / pharmacology

来  源:   DOI:10.3390/molecules26051308   PDF(Sci-hub)   PDF(Pubmed)

Abstract:
When skin is exposed to UV radiation, melanocytes produce melanin. Excessive melanin production leads to skin pigmentation, which causes various cosmetic and health problems. Therefore, the development of safe, natural therapeutics that inhibit the production of melanin is necessary. Elaeagnus umbellata (EU) has long been widely used as a folk medicinal plant because of pharmacological properties that include anti-ulcer, antioxidant, and anti-inflammatory properties. In this study, we investigated the antioxidant activity and melanogenesis inhibitory effects of EU fractions in B16-F10 melanoma cells. EU fractions showed a dose-dependent increase in antioxidant activity in radical scavenging activity. In addition, we evaluated the effect of EU fractions on tyrosinase activity and melanogenesis in α-melanocyte-stimulating hormone-induced B16-F10 melanoma cells. EU was noncytotoxic at 12.5-50 μg/mL. EU fractions effectively inhibited tyrosinase activity and melanogenesis, suppressed the phosphorylation of CREB and ERK involved in the melanogenesis pathway, and down-regulated expression of melanogenesis-related proteins. Interestingly, the anti-melanogenesis effect was most effective at a concentration of 50 μg/mL EU, and the effects of the fractions were superior to those of the extract. Therefore, our study suggests that EU has potential as a safe treatment for excessive pigmentation or as a natural ingredient in cosmetics.
摘要:
暂无翻译
公众号